Diabetes, Vol 42, Issue 12 1708-1714, Copyright © 1993 by American Diabetes Association

ARTICLES

Localization of a type I diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene

D Owerbach and KH Gabbay
Diabetes Research Center, Baylor College of Medicine, Houston, TX 77030.

A susceptibility gene for type I diabetes is present on chromosome 11p15.5, but its location, identity, and mechanism of action are unknown. We have sequenced 14 kilobases of DNA flanking the human insulin gene and found new DNA polymorphisms and determined their frequencies in the general population and in families of type I diabetic subjects. A DNA polymorphism located 3123 base pairs downstream from the initiation site of transcription of the insulin gene, when present in the homozygous state, provides a relative risk for type I diabetes of 5.2 (P = 0.006). However, this DNA polymorphism as well as other diabetes-associated 3' markers are in linkage-disequilibrium with the actual susceptibility region, because these polymorphisms are found on haplotypes both positively and negatively associated with type I diabetes susceptibility. Nucleotide sequence analysis of the variable tandem repeat region flanking the 5' end of the insulin gene shows variable tandem repeat elements associated with these haplotypes to differ greatly in composition, i.e., an ATAGGGGTGTGGGG repeat element is absent on a haplotype associated with type I diabetes susceptibility, but is found in 6-10 copies on two haplotypes negatively associated with the disease. These findings suggest that the type I diabetes susceptibility locus on chromosome 11p15.5 is probably located in the 5' variable tandem repeat region rather than in the 3' region of the insulin gene.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Gelfand, A. Rodriguez, and G. Benson TRDB--The Tandem Repeats Database Nucleic Acids Res., January 12, 2007; 35(suppl_1): D80 - D87. [Abstract] [Full Text] [PDF]

				B. J. Barratt, F. Payne, C. E. Lowe, R. Hermann, B. C. Healy, D. Harold, P. Concannon, N. Gharani, M. I. McCarthy, M. G. Olavesen, et al. Remapping the Insulin Gene/IDDM2 Locus in Type 1 Diabetes Diabetes, July 1, 2004; 53(7): 1884 - 1889. [Abstract] [Full Text] [PDF]

				J. D.H. Stead, M. E. Hurles, and A. J. Jeffreys Global Haplotype Diversity in the Human Insulin Gene Region Genome Res., September 1, 2003; 13(9): 2101 - 2111. [Abstract] [Full Text] [PDF]

				P. Vafiadis, H. Ounissi-Benkalha, M. Palumbo, R. Grabs, M. Rousseau, C. G. Goodyer, and C. Polychronakos Class III Alleles of the Variable Number of Tandem Repeat Insulin Polymorphism Associated with Silencing of Thymic Insulin Predispose to Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3705 - 3710. [Abstract] [Full Text] [PDF]

				J. D.H. Stead, J. Buard, J. A. Todd, and A. J. Jeffreys Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes Hum. Mol. Genet., December 1, 2000; 9(20): 2929 - 2935. [Abstract] [Full Text] [PDF]

				P. Vafiadis, S. T. Bennett, J. A. Todd, R. Grabs, and C. Polychronakos Divergence between Genetic Determinants of IGF2 Transcription Levels in Leukocytes and of IDDM2-Encoded Susceptibility to Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2933 - 2939. [Abstract] [Full Text]

				Y. Kominato, T. Tsuchiya, N. Hata, H. Takizawa, and F.-i. Yamamoto Transcription of Human ABO Histo-blood Group Genes Is Dependent upon Binding of Transcription Factor CBF/NF-Y to Minisatellite Sequence J. Biol. Chem., October 10, 1997; 272(41): 25890 - 25898. [Abstract] [Full Text] [PDF]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]

				T. Krontiris Minisatellites and human disease Science, September 22, 1995; 269(5231): 1682 - 1683. [PDF]